2004 Annual Meeting | Therapy of Pediatric Genetic Neurological Disorders

�鶹��ýӳ��

2004 Annual Meeting | Therapy of Pediatric Genetic Neurological Disorders

Date Monday 04/26/04

Time 06:30 PM - 09:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Dinner Seminar

Director(s) E. S. Roach, MD, F�鶹��ýӳ��

Topic(s) Neurogenetics/Neurometabolic Disorders/Neurotoxicology

Learning Objectives Upon completion:
Participants should be able to know the general approaches to treatment of genetic disorders affecting the nervous system; recognize the clinical features of selected genetic disorders for which treatment is available; and know the treatment of various genetic neurological disorders.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
06:30 PM - 06:40 PM		Introduction
06:40 PM - 07:30 PM		Molecular Mechanisms of Treatable Genetic Disorders Keith Hyland, PhD
07:30 PM - 08:20 PM		Dietary and Nutrient Therapy E. S. Roach, MD, F�鶹��ýӳ��
08:20 PM - 09:10 PM		Gene and Gene Product Replacement Michael M. Dowling, MD, PhD, F�鶹��ýӳ��
09:10 PM - 09:30 PM		Questions and Answers

Faculty Disclosures
E. S. Roach, MD, F�鶹��ýӳ��	No disclosure on file
Keith Hyland, PhD	No disclosure on file
	No disclosure on file
Michael M. Dowling, MD, PhD, F�鶹��ýӳ��	Dr. Dowling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Dowling has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NHLBI. The institution of Dr. Dowling has received research support from NIH.